Downloads: 157
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
14_0165.pdf | 261.9 kB | Adobe PDF | View/Open |
Title: | 泌尿器科領域におけるTrasylolの治験 |
Other Titles: | Some clinical experiences with "Trasylol" in urological diseases |
Authors: | 小田, 完五 ![]() 大山, 朝弘 ![]() 三品, 輝男 ![]() 宮谷, 勝明 ![]() |
Author's alias: | Oda, Kangi Oyama, Choko Mishina, Teruo Miyatani, Katsuaki |
Keywords: | Adult Aged Aprotinin/therapeutic use Female Fibrinolysis/drug effects Hemostatics/therapeutic use Humans Male Middle Aged Postoperative Care Urologic Diseases/drug therapy |
Issue Date: | Feb-1968 |
Publisher: | 京都大学医学部泌尿器科学教室 |
Journal title: | 泌尿器科紀要 |
Volume: | 14 |
Issue: | 2 |
Start page: | 165 |
End page: | 169 |
Abstract: | Anti•plasmin agent, "Trasylol", was administered to operative patients, which included four cases of prostatic hypertrophy, each two of prostatic cancer, ureteral calculus and bladder tumor, each one of papillomatosis of urinary tract, renal tuberculosis, pyonephrosis, perinephritis and renal calculus. Trasylol produced a rapid and effective inhibition of plasmin activity. Based on these results, it is supposed that Trasylol is one of the useful anti-plasmin agents. No noticeable side effect was encountered in all patients treated. |
URI: | http://hdl.handle.net/2433/119832 |
PubMed ID: | 5302938 |
Appears in Collections: | Vol.14 No.2 |

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.